When the liver is badly scarred by cirrhosis, the consequences are not just digestive. It can creep up and affect your brain ...

Wegovy is now approved by the FDA to treat metabolic-associated steatohepatitis in adults with moderate-to-advanced fibrosis ...

With a new endorsement from the FDA, Novo Nordisk’s Wegovy has picked up its third indication and become the second drug ...

Wegovy is the first GLP-1 drug approved to treat adults with metabolic dysfunction-associated steatohepatitis (MASH). An ...

The glucagon-like peptide-1 (GLP-1) receptor agonist gained accelerated approval for patients with MASH and moderate to ...

In moderate to severe Crohn's disease, a network meta-analysis suggested that TNF inhibitor-based therapy was the most ...

Cirrhosis or fibrosis of the liver can occur due to several liver-related diseases and conditions, such as hepatitis, non-alcoholic fatty liver disease, and excessive alcohol consumption.

Men with cirrhosis have a significantly higher risk for liver-related complications ― particularly hepatocellular carcinoma ― ...

Cirrhosis is also associated with an enlarged spleen that may entrap platelets, the blood cells involved in clotting; so measuring a person's platelet count can be useful in diagnosing the liver ...

In patients with hepatocellular carcinoma (HCC), hyponatremia is an independent predictor of increased rates of in-hospital mortality, with a greater impact reported among those with cirrhosis, ...

Current guidelines for patients with cirrhosis and upper-GI bleeding recommend 5 to 7 days of antibiotic prophylaxis to ...

Liver cirrhosis, also known as the fourth and most advanced stage of fibrosis, can result from a variety of causes including nonalcoholic fatty liver disease and very often from alcohol-related ...